Availability of the Drugs for Malignant Diseases Treatment: Comparison between Developing and Developed Countries
Ankica Jelenković, Marija Ristić, Ivica Pejčić, Dušan Ristić & Bogdan Bošković · Journal of Pharmaceutical Research International · 2014
Aim: The financial burden of malignant diseases treatment has increased remarkably over the years. This is due to, among many reasons, the costs of drugs, especially those of the new classes. Thus, it is of interest to assess the availability and differential cost of anti-cancer...
Open access
Research Article
10.9734/BJPR/2014/9595